Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medipharm Labs (Otc) (TSE:LABS)
:LABS
Holding TSE:LABS?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
>-0.01Last Year’s EPS
>-0.01Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 10, 2019
|% Change Since: -12.50%
|Next Earnings Date:May 10, 2019
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook, with significant progress towards profitability and strong international sales growth, particularly in Germany and Australia. The company also highlighted a strong balance sheet with minimal debt. However, challenges remain in the Canadian market and the broader cannabis industry, impacting overall sentiment.Company Guidance
During MediPharm Labs' Q2 2024 earnings call, the company provided an optimistic outlook as it approaches profitability, reporting an adjusted EBITDA loss of only $124,000, a substantial improvement from over $6 million in losses two years prior. The call highlighted strategic initiatives, including the recent integration of Canna Farms Medical into the Barrie operation, which reduced costs, and the planned sale of the Hope Facility to enhance financials further. With international sales comprising over 40% of revenues, the company emphasized its strong international presence, particularly in Europe, Australia, and Brazil, and expects future growth with ongoing pharmaceutical partnerships. The company's revenue reached $10.3 million, the highest in over three years, with gross profit margins also at a four-year high of 37%. The management expressed confidence in leveraging its strong cash position of $16 million and minimal debt of less than $3 million to pursue growth opportunities while maintaining a focus on cost efficiency.Approaching Profitability
The company reported being close to breakeven with an adjusted EBITDA loss of $124,000, improving from a loss of over $6 million per quarter in Q2 2022.
International Sales Growth
International sales contributed over 40% of total revenues, with significant growth in markets like Germany and Australia.
Strong Balance Sheet
The company ended the quarter with $16 million in cash and plans to sell underutilized assets, potentially generating an additional $4-5 million.
High Gross Margin
Gross profit for Q2 was 33%, which is the highest in over four years, driven by increased international medical cannabis revenue.
Expansion in Germany
Sales to German pharma partner STADA increased by 35% compared to the first half of 2023, with significant growth in oil and flower units.
---
TSE:LABS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:LABS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | C$0.08 | C$0.07 | -12.50% |
| Aug 14, 2024 | C$0.07 | C$0.07 | 0.00% |
| May 15, 2024 | C$0.09 | C$0.08 | -5.88% |
| Mar 27, 2024 | C$0.10 | C$0.09 | -5.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Medipharm Labs (Otc) (TSE:LABS) report earnings?
Medipharm Labs (Otc) (TSE:LABS) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Medipharm Labs (Otc) (TSE:LABS) earnings time?
Medipharm Labs (Otc) (TSE:LABS) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:LABS EPS forecast?
TSE:LABS EPS forecast for the fiscal quarter 2024 (Q4) is >-0.01.
---